| scholarly article | Q13442814 |
| P2093 | author name string | Wei Luo | |
| Candace S Johnson | |||
| Donald L Trump | |||
| Wei-Dong Yu | |||
| Yingyu Ma | |||
| Alejandro A Hidalgo | |||
| Remi Delansorne | |||
| P2860 | cites work | Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men | Q22242854 |
| The role of vitamin D in cancer prevention | Q24545572 | ||
| CYP24A1 inhibition enhances the antitumor activity of calcitriol | Q34132307 | ||
| The activation of Akt/PKB signaling pathway and cell survival. | Q34405519 | ||
| Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription | Q35378668 | ||
| Inecalcitol, an analog of 1α,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells | Q35782892 | ||
| The emerging role of the PI3-K-Akt pathway in prostate cancer progression | Q36050987 | ||
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 | ||
| 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model | Q36982956 | ||
| Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer | Q39687107 | ||
| Glucocorticoid regulation of the vitamin D receptor | Q39882237 | ||
| Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell car | Q40243286 | ||
| Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase | Q40504176 | ||
| Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy | Q40883301 | ||
| Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo | Q43503491 | ||
| Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells | Q43508934 | ||
| Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. | Q43579777 | ||
| Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements | Q43584307 | ||
| Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. | Q43594118 | ||
| Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells | Q44033494 | ||
| The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro | Q44225920 | ||
| Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer. | Q44246934 | ||
| Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. | Q44255811 | ||
| Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses | Q44805762 | ||
| Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction | Q45280602 | ||
| Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system | Q73677763 | ||
| Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone | Q74121283 | ||
| 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo | Q77861542 | ||
| Vitamin D | Q78117743 | ||
| P433 | issue | 5 | |
| P921 | main subject | squamous cell carcinoma | Q681817 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 743-752 | |
| P577 | publication date | 2013-02-06 | |
| P1433 | published in | Cell Cycle | Q1254166 |
| P1476 | title | Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system | |
| P478 | volume | 12 |
| Q37133523 | 1,25-Dihydroxyvitamin D3 modulates calcium transport in goat mammary epithelial cells in a dose- and energy-dependent manner |
| Q39027140 | 1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells |
| Q91938922 | Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness |
| Q61023219 | Calcitriol and cancer therapy: A missed opportunity |
| Q92107832 | Centromere Protein N Participates in Cellular Proliferation of Human Oral Cancer by Cell-Cycle Enhancement |
| Q57279890 | Chapter 20: Update on Pharmacologically-Relevant Vitamin D Analogs |
| Q47647199 | DHPLC Elution Patterns of VDR PCR Products Can Predict Prostate Cancer Susceptibility in African American Men. |
| Q37060783 | Effects of 1,25(OH)2D3 on proliferation and apoptosis of human glomerular mesangial cells |
| Q93015032 | Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment |
| Q88924562 | Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies |
| Q37695300 | The future of vitamin D analogs |
| Q85696571 | The role of vitamin D in cancer prevention |
| Q38412880 | Vitamin D in cancer chemoprevention |
| Q55024961 | Vitamin D in prostate cancer. |
| Q87491446 | Vitamin D inhibition of lung adenocarcinoma cell proliferation in vitro |
| Q99405236 | Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway |
Search more.